PAR 3.77% 25.5¢ paradigm biopharmaceuticals limited..

Passing the test and guess what, A Mozz Bonus, page-7

  1. 584 Posts.
    lightbulb Created with Sketch. 134
    I believe it is the Baker Young research report. Haven't been able to find it under research reports but I'm sure someone will post it. Some unbelievable quotes in there. Also liked seeing where the early participants were now. All of them not needing knee replacements. Private health insurers take note.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.